ERNA

Eterna Therapeutics Inc. - Common Stock (ERNA)

About Eterna Therapeutics Inc. - Common Stock (ERNA)

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Details

Daily high

$1.32

Daily low

$1.22

Price at open

$1.30

52 Week High

$14.40

52 Week Low

$1.09

Market cap

10.1M

Dividend yield

0.00%

Volume

27,796

Avg. volume

47,494

P/E ratio

-.27

Eterna Therapeutics Inc. - Common Stock News